CK Life Sciences Email Format
Biotechnology ResearchHong Kong51-200 Employees
CK Life Sciences Int’l., (Holdings) Inc. is a biotechnology research company based in Hong Kong with 51-200 employees, listed on the Stock Exchange of Hong Kong (stock code 0775) and a member of the CK Hutchison Group. The company conducts research and development, manufacturing, commercialization, marketing, and sale of products, as well as investments in assets, across three core categories: nutraceuticals, pharmaceuticals, and agriculture-related items. It operates within the biotechnology and life sciences sectors, delivering products and services through its three core categories. The firm has engaged in strategic external collaborations and investments, including a 2025 investment in TransCode Therapeutics and a 2024 merger with Virios Therapeutics. More information is available on its website at https://ck-lifesciences.com.